| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
APOLLOHOSP Stock Overview
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally.
Apollo Hospitals Enterprise Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹4,644.80 |
| 52 Week High | ₹5,935.40 |
| 52 Week Low | ₹2,528.10 |
| Beta | 0.47 |
| 1 Month Change | -4.18% |
| 3 Month Change | 15.30% |
| 1 Year Change | 79.68% |
| 3 Year Change | 253.31% |
| 5 Year Change | 280.15% |
| Change since IPO | 27,142.23% |
Recent News & Updates
I Ran A Stock Scan For Earnings Growth And Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Passed With Ease
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
We Think Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Can Manage Its Debt With Ease
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Returns On Capital Are Showing Encouraging Signs At Apollo Hospitals Enterprise (NSE:APOLLOHOSP)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Shareholder Returns
| APOLLOHOSP | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -6.8% | -5.9% | -1.1% |
| 1Y | 79.7% | 60.7% | 32.6% |
Return vs Industry: APOLLOHOSP exceeded the Indian Healthcare industry which returned 63.4% over the past year.
Return vs Market: APOLLOHOSP exceeded the Indian Market which returned 34.4% over the past year.
Price Volatility
| APOLLOHOSP volatility | |
|---|---|
| APOLLOHOSP Average Weekly Movement | 6.4% |
| Healthcare Industry Average Movement | 5.8% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 9.9% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: APOLLOHOSP is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: APOLLOHOSP's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 68,496 | Suneeta Reddy | https://www.apollohospitals.com |
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The company’s healthcare facilities comprise primary, secondary, and tertiary care facilities. Its tertiary care hospitals provide care in approximately 60 specialties, including cardiac sciences, oncology, critical care, neurosciences, orthopedics, gastroenterology, and transplants.
Apollo Hospitals Enterprise Fundamentals Summary
| APOLLOHOSP fundamental statistics | |
|---|---|
| Market Cap | ₹649.32b |
| Earnings (TTM) | ₹10.35b |
| Revenue (TTM) | ₹131.05b |
64.5x
P/E Ratio5.1x
P/S RatioIs APOLLOHOSP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| APOLLOHOSP income statement (TTM) | |
|---|---|
| Revenue | ₹131.05b |
| Cost of Revenue | ₹86.72b |
| Gross Profit | ₹44.33b |
| Expenses | ₹33.98b |
| Earnings | ₹10.35b |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 72.01 |
| Gross Margin | 33.83% |
| Net Profit Margin | 7.90% |
| Debt/Equity Ratio | 52.9% |
How did APOLLOHOSP perform over the long term?
See historical performance and comparisonDividends
0.06%
Current Dividend Yield4%
Payout RatioValuation
Is Apollo Hospitals Enterprise undervalued compared to its fair value and its price relative to the market?
64.5x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: APOLLOHOSP (₹4515.95) is trading above our estimate of fair value (₹2604)
Significantly Below Fair Value: APOLLOHOSP is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: APOLLOHOSP is poor value based on its PE Ratio (62.7x) compared to the Indian Healthcare industry average (32x).
PE vs Market: APOLLOHOSP is poor value based on its PE Ratio (62.7x) compared to the Indian market (23.4x).
Price to Earnings Growth Ratio
PEG Ratio: APOLLOHOSP is poor value based on its PEG Ratio (3.6x)
Price to Book Ratio
PB vs Industry: APOLLOHOSP is overvalued based on its PB Ratio (12.2x) compared to the IN Healthcare industry average (3.5x).
Future Growth
How is Apollo Hospitals Enterprise forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?
17.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: APOLLOHOSP's forecast earnings growth (17.3% per year) is above the savings rate (6.7%).
Earnings vs Market: APOLLOHOSP's earnings (17.3% per year) are forecast to grow slower than the Indian market (20.8% per year).
High Growth Earnings: APOLLOHOSP's earnings are forecast to grow, but not significantly.
Revenue vs Market: APOLLOHOSP's revenue (14.9% per year) is forecast to grow faster than the Indian market (13.2% per year).
High Growth Revenue: APOLLOHOSP's revenue (14.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: APOLLOHOSP's Return on Equity is forecast to be high in 3 years time (21.3%)
Past Performance
How has Apollo Hospitals Enterprise performed over the past 5 years?
32.6%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: APOLLOHOSP has a large one-off gain of ₹3.2B impacting its September 30 2021 financial results.
Growing Profit Margin: APOLLOHOSP's current net profit margins (7.9%) are higher than last year (1.5%).
Past Earnings Growth Analysis
Earnings Trend: APOLLOHOSP's earnings have grown significantly by 32.6% per year over the past 5 years.
Accelerating Growth: APOLLOHOSP's earnings growth over the past year (533.1%) exceeds its 5-year average (32.6% per year).
Earnings vs Industry: APOLLOHOSP earnings growth over the past year (533.1%) exceeded the Healthcare industry 112.9%.
Return on Equity
High ROE: APOLLOHOSP's Return on Equity (19.4%) is considered low.
Financial Health
How is Apollo Hospitals Enterprise's financial position?
Financial Position Analysis
Short Term Liabilities: APOLLOHOSP's short term assets (₹43.4B) exceed its short term liabilities (₹26.5B).
Long Term Liabilities: APOLLOHOSP's short term assets (₹43.4B) do not cover its long term liabilities (₹47.4B).
Debt to Equity History and Analysis
Debt Level: APOLLOHOSP's net debt to equity ratio (25.6%) is considered satisfactory.
Reducing Debt: APOLLOHOSP's debt to equity ratio has reduced from 87.1% to 52.9% over the past 5 years.
Debt Coverage: APOLLOHOSP's debt is well covered by operating cash flow (51.1%).
Interest Coverage: APOLLOHOSP's interest payments on its debt are well covered by EBIT (4.3x coverage).
Balance Sheet
Dividend
What is Apollo Hospitals Enterprise current dividend yield, its reliability and sustainability?
0.064%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: APOLLOHOSP's dividend (0.066%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.3%).
High Dividend: APOLLOHOSP's dividend (0.066%) is low compared to the top 25% of dividend payers in the Indian market (1.33%).
Stability and Growth of Payments
Stable Dividend: APOLLOHOSP is not paying a notable dividend for the Indian market, therefore no need to check if payments are stable.
Growing Dividend: APOLLOHOSP is not paying a notable dividend for the Indian market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: APOLLOHOSP is not paying a notable dividend for the Indian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of APOLLOHOSP's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
10.8yrs
Average management tenure
CEO
Suneeta Reddy (62 yo)
7.5yrs
Tenure
₹29,120,000
Compensation
Mrs. Suneeta Reddy has been Managing Director of Apollo Hospitals Enterprise Ltd. since July 2, 2014. Mrs. Reddy has been an Independent Director at Apeejay Surrendra Park Hotels Limited since December 23,...
CEO Compensation Analysis
Compensation vs Market: Suneeta's total compensation ($USD390.46K) is below average for companies of similar size in the Indian market ($USD902.14K).
Compensation vs Earnings: Suneeta's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: APOLLOHOSP's management team is seasoned and experienced (10.8 years average tenure).
Board Members
Experienced Board: APOLLOHOSP's board of directors are considered experienced (7.5 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: APOLLOHOSP insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.3%.
Top Shareholders
Company Information
Apollo Hospitals Enterprise Limited's employee growth, exchange listings and data sources
Key Information
- Name: Apollo Hospitals Enterprise Limited
- Ticker: APOLLOHOSP
- Exchange: NSEI
- Founded: 1979
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: ₹649.324b
- Shares outstanding: 143.78m
- Website: https://www.apollohospitals.com
Number of Employees
Location
- Apollo Hospitals Enterprise Limited
- Sunny Side Building
- 3rd Floor
- Chennai
- Tamil Nadu
- 600006
- India
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/01/20 12:03 |
| End of Day Share Price | 2022/01/20 00:00 |
| Earnings | 2021/09/30 |
| Annual Earnings | 2021/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.